Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: Case report | Zendy

Cossu Giovanni | Zendy; Melis Maurizio | Zendy; Melis Giannina | Zendy; Maccioni Elisabetta | Zendy; Putzu Valeria | Zendy; Catte Olga | Zendy; Putzu Paolo Francesco | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: Case report

Author(s) -

Cossu Giovanni,

Melis Maurizio,

Melis Giannina,

Maccioni Elisabetta,

Putzu Valeria,

Catte Olga,

Putzu Paolo Francesco

Publication year - 2004

Publication title -

movement disorders

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.352

H-Index - 198

eISSN - 1531-8257

pISSN - 0885-3185

DOI - 10.1002/mds.20164

Subject(s) - galantamine , cholinesterase , botulinum toxin , medicine , degenerative disease , neurological disorder , disease , psychology , central nervous system disease , donepezil , anesthesia , pharmacology , dementia

We report on a case of reversible Pisa syndrome developed after treatment with galantamine in a patient with Alzheimer's disease without previous exposure to neuroleptic or other cholinesterase inhibitors. Complete and persistent resolution of the syndrome was achieved several weeks after botulinum toxin type‐A injection. © 2004 Movement Disorder Society

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research